Jaxon James Fernandes, MD | |
1 Clara Maass Dr, Belleville, NJ 07109-3550 | |
(973) 450-2000 | |
Not Available |
Full Name | Jaxon James Fernandes |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 31 Years |
Location | 1 Clara Maass Dr, Belleville, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073675740 | NPI | - | NPPES |
0125237 | Medicaid | NJ | |
P00399307 | Other | NJ | RAIL ROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 25MA08153000 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Clara Maass Medical Center | Belleville, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rwjbh Emergency Medicine Associates, Llc | 0941612840 | 613 |
News Archive
Encouraging hospital births are an important component of reducing maternal mortality in low-resource settings. Now, new research shows certain factors, including age and income, determine whether women living in rural Nepal have home births or hospital deliveries.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the second quarter ended June 30, 2010.
Young adults who spend a lot of time on social media during the day or check it frequently throughout the week are more likely to suffer sleep disturbances than their peers who use social media less, according to new research from the University of Pittsburgh School of Medicine.
Researchers from New England report in a new study that using a tumor marker, serum CA 19-9, combined with an endoscopic ultrasound if the tumor marker is elevated, is more likely to detect stage 1 pancreatic cancer in a high-risk population than by using the standard means of detection.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
› Verified 2 days ago
Entity Name | Rwjbh Emergency Medicine Associates, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912510041 PECOS PAC ID: 0941612840 Enrollment ID: O20201217002547 |
News Archive
Encouraging hospital births are an important component of reducing maternal mortality in low-resource settings. Now, new research shows certain factors, including age and income, determine whether women living in rural Nepal have home births or hospital deliveries.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the second quarter ended June 30, 2010.
Young adults who spend a lot of time on social media during the day or check it frequently throughout the week are more likely to suffer sleep disturbances than their peers who use social media less, according to new research from the University of Pittsburgh School of Medicine.
Researchers from New England report in a new study that using a tumor marker, serum CA 19-9, combined with an endoscopic ultrasound if the tumor marker is elevated, is more likely to detect stage 1 pancreatic cancer in a high-risk population than by using the standard means of detection.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Jaxon James Fernandes, MD Po Box 708640, Sandy, UT 84070-8640 Ph: (866) 869-2395 | Jaxon James Fernandes, MD 1 Clara Maass Dr, Belleville, NJ 07109-3550 Ph: (973) 450-2000 |
News Archive
Encouraging hospital births are an important component of reducing maternal mortality in low-resource settings. Now, new research shows certain factors, including age and income, determine whether women living in rural Nepal have home births or hospital deliveries.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the second quarter ended June 30, 2010.
Young adults who spend a lot of time on social media during the day or check it frequently throughout the week are more likely to suffer sleep disturbances than their peers who use social media less, according to new research from the University of Pittsburgh School of Medicine.
Researchers from New England report in a new study that using a tumor marker, serum CA 19-9, combined with an endoscopic ultrasound if the tumor marker is elevated, is more likely to detect stage 1 pancreatic cancer in a high-risk population than by using the standard means of detection.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
› Verified 2 days ago
Dr. Etan B Spira, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5 Franklin Ave, Suite 109, Belleville, NJ 07109 Phone: 973-759-7240 Fax: 973-759-7243 | |
Dr. Jimmy Martins Paulo, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr Ste 202, Belleville, NJ 07109 Phone: 973-450-2433 Fax: 973-450-2434 | |
Hemalatha Vasireddy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr Ste 200, Belleville, NJ 07109 Phone: 973-751-8880 Fax: 973-751-8950 | |
Dr. Mario A Criscito, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 50 Newark Ave, Suite 204, Belleville, NJ 07109 Phone: 973-450-2158 Fax: 973-450-2027 | |
John Daconti, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 77 Newark Ave, Suite 3 & 4, Belleville, NJ 07109 Phone: 973-528-2160 Fax: 973-528-2165 | |
Dr. Dianne Walker, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 Belmont Ave, Belleville, NJ 07109 Phone: 973-751-4818 Fax: 973-751-4886 |